Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F de Braud

Showing results (41-50 of 140) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2015
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumorsF de Braud, S Cascinu, G Spitaleri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2006
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapyG Curigliano, V Formica, T De Pas, et al.
European Journal of Nuclear Medicine|September 2, 1998
Combined treatment of advanced oropharyngeal cancer with external radiotherapy and three-step radioimmunotherapyG Paganelli, R Orecchia, B Jereczek-Fossa, et al.
Hepato-Gastroenterology|March 13, 2003
Iatrogenic gastroduodenal ulcers during hepatic intra-arterial chemotherapyD Ravizza, N Fazio, G Fiori, et al.
Anticancer Research|February 19, 2002
GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysisG Curigliano, G Ferretti, M Mandalà, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabineT De Pas, F de Braud, M Mandalà, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2011
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS studyC Bokemeyer, I Bondarenko, J T Hartmann, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2015
Disease progression pattern in metastatic breast cancer patients treated with anti-HER2 therapiesD Serpico, L Porcu, A Tessari, et al.
Tumori|November 6, 2001
Is there a real advantage in utilizing central venous ports in oncology surgery? An analysis of the cost-effectiveness ratioR Biffi, S Pozzi, U Pace, et al.
Analytical and Quantitative Cytology and Histology|October 1, 1993
Keratins 6, 13 and 19. Differential expression in squamous cell carcinoma of the head and neckJ Klijanienko, A el-Naggar, F De Braud, et al.
Pageof 14

Showing results (41-50 of 140) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2015
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumorsF de Braud, S Cascinu, G Spitaleri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2006
Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapyG Curigliano, V Formica, T De Pas, et al.
European Journal of Nuclear Medicine|September 2, 1998
Combined treatment of advanced oropharyngeal cancer with external radiotherapy and three-step radioimmunotherapyG Paganelli, R Orecchia, B Jereczek-Fossa, et al.
Hepato-Gastroenterology|March 13, 2003
Iatrogenic gastroduodenal ulcers during hepatic intra-arterial chemotherapyD Ravizza, N Fazio, G Fiori, et al.
Anticancer Research|February 19, 2002
GSTM1, P53 and K-ras molecular detection in resectable non-small cell lung cancer by denaturing gradient gel electrophoresis-bronchoalveolar lavage fluid analysisG Curigliano, G Ferretti, M Mandalà, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabineT De Pas, F de Braud, M Mandalà, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2011
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS studyC Bokemeyer, I Bondarenko, J T Hartmann, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 22, 2015
Disease progression pattern in metastatic breast cancer patients treated with anti-HER2 therapiesD Serpico, L Porcu, A Tessari, et al.
Tumori|November 6, 2001
Is there a real advantage in utilizing central venous ports in oncology surgery? An analysis of the cost-effectiveness ratioR Biffi, S Pozzi, U Pace, et al.
Analytical and Quantitative Cytology and Histology|October 1, 1993
Keratins 6, 13 and 19. Differential expression in squamous cell carcinoma of the head and neckJ Klijanienko, A el-Naggar, F De Braud, et al.
Pageof 14